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Quantitative techniques for accurately measuring the compo-
nents of glomerular immune deposits have been developed over
several years. These techniques rely on the observations of
Yalow and Berson [1] who showed that it is possible to ra-
diolabel proteins and peptides without substantially altering
their antigenicity. Johnson, Day and Pressman [21, and Mc-
Conahey and Dixon [3] later demonstrated that similar tech-
niques can be used to iodinate immunoglobulins (Ig) in such a
way that they retain antibody function.
In this review, we will illustrate some of the uses of quanti-
tative techniques in the study of immunological glomerular
disease and its pathophysiological consequences. Table 1 sum-
marizes several such uses, but the range of possible applica-
tions is limited only by the imagination and inventiveness of the
investigator. Specific methodological details will not be in-
cluded here since these are generally straightforward and are
well described [4—10]. We will also tend to concentrate on the
measurement of antibodies and antigens that form immune
deposits within glomeruli. However, isotopic techniques have
also been used extensively to measure the plasma clearance and
organ localization of infused preformed immune complexes [II,
121 and to study the mesangial uptake and clearance of macro-
molecules in normal and disease states [13, 141. Notwithstand-
ing certain limitations and potential pitfalls that will be illus-
trated and discussed, these techniques provide a powerful,
sensitive, accurate and reproducible tool that is far superior to
semiquantitative immunofluorescent (IF) microscopy. Immuno-
fluorescence is subjective, often not reproducible from one
observer to another and sensitive only to values above 0.25 g
protein/g kidney [61. Although the newly—developed technique
of fluorescence microfluorophotometry provides a much more
objective and quantitative assessment of immunofluorescent
staining intensity [15—17], relatively expensive and sophisti-
cated equipment is required, and, as yet, the degree of cor-
relation between antibody binding measured isotopically and
that measured photometrically has not been determined.
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Purification, characterization and radiolabelling of antibodies
Isolation of IgG
Several methods are available for purifying antibody from
whole antiserum for radiolabelling. The methods selected will
ultimately be determined by the requirement of the experiments
in which the antibody is to be used. When relatively large
amounts of antibody are needed (such as to produce a biological
effect), a preparation of the serum IgG fraction (containing the
antibody) is often adequate and most practical. This is conven-
tionally accomplished with ion—exchange chromatography [41
but, for certain animal species, staphylococcal protein A-
Sepharose CL-4B (Pharmacia Fine Chemicals, Piscataway,
New Jersey, USA) affinity chromatography [18] is a rapid and
effective alternative. A small fraction of the IgO preparation is
taken for iodination and can then be added back to the "cold"
fraction to serve as a tracer.
Affinity—purification qf antibody
As discussed later, certain experimental conditions are best
suited to the use of affinity—purified antibodies. These are
prepared by affinity chromatography [19], which requires that
the relevant purified antigen be available in a form that can he
coupled to a support such as CNBr-Sepharose (Pharmacia Fine
Chemicals). It must be emphasized, however, that conditions
used to elute antibody from the immobilized antigen, whether
by a specific competitor, or nonspecifically by acid, chaotropic
ion, or denaturing agent, may alter the binding characteristics
and biological activity of the antibody, such that it is no longer
truly representative of the original preparation [20]. Thus,
before using labelled, affinity—purified antibody as a tracer in
whole antiserum or in immune IgG, one should ascertain that its
binding properties have not been altered and that the purified
preparation has truly been enriched for antigen—specific IgG.
Specificity of antisera
As is true of all immunolocalization techniques, the confi-
dence with which one can make statements regarding the
quantitative binding to a given antigen depends on the speci-
ficity of the labelled antiserum. Thus an antiserum to crude
cortical homogenate may appear, by IF, to bind only to GBM
and may be ideal for inducing glomerular injury, but it is likely
that it has specificity for many cellular and matrix components
[21]. On the other hand, one might obtain very precise quanti-
255
256 Sn/ant et a!
2. Organ distribution
3. Plasma clearance
4. Kinetics of renal/glomerular localization and
clearance
5. Nephritogenicity
6. Effects on above of:
a. antibody properties (avidity, charge, FcR
binding)
b. antigen properties (quantity, charge,
valence)
c. immune complex properties (size, charge,
C-fixation)
d. systemic and local renal factors
(hemodynamics, glomerular charge, MPS
function, CR!
e. therapeutic manipulations
B. Quantitation of endogenous antibodies
Abbreviations are: FcR, Fe receptor; MPS, mononuclear—phagocyte
system; C, complement; CR1, C3b receptor, Citations are selected,
illustrative examples of tabulated uses of quantitative techniques.
Group GAb
Urine protein
excretion
Norma! (5)
IgG/l04 glomeruli
15.8 2.7!
mg/g creatinine
42.0 26.3
C6D (6) 18.7 1.99 5.1 5.5
Rabbits were intravenously injected with sheep anti-rabbit GBM IgG
(12 mg/kg) trace labelled with 251. Since kidneys were not perfused
with saline, GAb was corrected for nonspecific binding by the double—
isotope technique [5, 61 using non-immune sheep IgG-°1l as a plasma
marker. Number of rabbits studied is in parentheses. Values are mean
SD.
tative information regarding the binding to a given glomerular
antigen by using monospecific heterologous [22] or monoclonal
antibodies [21] but induce little or no glomerular injury. Obvi-
ously, the choice of reagents between these two extremes will
depend on the aims and design of the study.
Characterization of antisera
Several other properties of lgG antibodies affect their ability
to bind to glomeruli in vivo and, having hound, to induce
disease. These are dealt with in more detail later, but should be
considered in planning experiments and even in the decision as
to which species an antiserum should be raised in. For example,
sheep IgG exists as two subclasses that differ with respect to
both charge and complement—fixing ability. Thus the more
cationic, nonconiplement—fixing 'y2 subclass can be easily and
completely separated from the more anionic, comple-
ment—fixing 'yl subclass by ion—exchange chromatography [23,
24]. While this might provide the opportunity of comparing the
binding or nephritogenic properties of these two subclasses in a
given antiserum, there is no guarantee that their respective
concentrations of antigen—specific IgG (antibody content) or
affinity for the relevant antigen are the same. Therefore, de-
References pending on experimental conditions, it may be necessary to
define the antibody content [15, 25], affinity [26], charge [10,
4,6,7,9,12—14, 25—27], complement—fixing [24], or other biological functions of
antisera selected for quantitative studies. Furthermore, con-
4,7,11,42 stancy of these characteristics should be confirmed after
4,7,13,14,42,46 radiolabelling.
Ideally, one would like to measure the binding affinity and
4,42 concentration of active antibody molecules before and after
10 11 25—27 iodination. This is readily achieved by equilibrium dialysis [28]
and similar techniques when one is dealing with haptens and
26,46,48,66 monoclonal antibodies. However, such measurements are
much more difficult to do and interpret when the reactants are
66,71,72 polyclonal antibodies and multivalent antigens, or when the
10,25,26,58, antigens are complex tissue—bound molecules not readily avail-
59,73,74 able in purified form. To assess the binding efficiency of labelled
antibodies to such tissue antigens, we have used the binding
9,24,49—52,60 titer on indirect IF [4]. For example, when the IgG fraction of
8 sheep anti-Fx IA was radioiodinated to a specific activity of 5
MCi/mg, both labelled and cold antibody preparations at the
same IgG concentration, hound to proximal tubular brush
border of normal rat kidney to the same dilutional end point.
We have also compared the relative affinity and antibody
content of affinity—purified anti-sheep lgG before and after
radioiodination (specific activity 110 j.tCi/mg), using a reverse
radial immunodiffusion assay [29, 301. In this assay, antigen
(rather than antibody) is incorporated into the gel, allowing one
to compare the regression lines relating immunoprecipitin ring
area to concentration of different antibody preparations. The
slopes of such lines provide a measure of the average affinities
of polyclonal antibody preparations 1301 and the elevations of
the lines reflect their antibody content at any given concentra-
tion. Since the regression lines before (y = 0.018 + 0.23) and
after (y = 0.017 + 0.21) iodination of anti-sheep IgG were
similar, we concluded that binding affinity and antibody content
were not adversely affected by the labelling procedure. We
have also used this technique to compare the relative affinities
of differently charged IgCJ fractions of affinity—purified anti-
sheep IgG [26].
When it is impossible to purify antibodies to complex glomer-
ular antigens, a measure of antibody content can he obtained by
incubating aliquots of glomeruli with subsaturating concentra-
tions of labelled antibody until binding equilibrium is reached
[10, 25]. Specificity of binding is ensured either by subtracting
glomerular—bound counts of labelled nonimmune IgG, prepared
and incubated under similar conditions with identically—sized
aliquots of glomeruli [23], or by adding an excess of cold
nonimmune lgG to the incubation mixture of antibodies [10].
The relative content of antigen—specific IgG in two dual—
labelled preparations can then be compared as a binding ratio
[101 or as a fraction of the amount added to the incubation
mixture [25]. This procedure does not provide information on
the relative affinity of each preparation, however.
lodination
For the purpose of quantitating antibody deposition in kid-
neys, in general, the full sensitivity potential of the radioimmu-
noassay is not required, We have used both 1251 and 1311 for
labelling antibody, but 3H [311 may also provide adequate
'fable 1. Potential and established applications of quantitative
techniques
A. Exogenous kidney—specific antibodies, antigens
or preformed immune complexes
I. Specific deposition in kidney/glomeruli
Table 2. Glomerular antibody binding (GAb) and urine protein
excretion 24 hours after administration of sheep anti-rabbit GBM to
normal and C6-deflcient (C6D) rabbits. From 191
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specific activities and could thcrefore be employed. Both iodine
isotopes may be used together for "pair—labelled" studies
because the energy spectra of the two are different and are
readily resolved into separate channels on a y counter [321.
When only one isotope is required, there is an obvious advan-
tage to using 25! over 131j because of its longer decay half—life
(60 versus 8 days). Furthermore, 1251 can be resolved from 14C
(but not 3H) in a f3 scintillation counter and from other
high—energy emitters, whereas the same is not uniformly true of
1311
Introduction of iodine into an antibody molecule may cause
denaturation, a change in p1 [321, or impairment of antigen
recognition, particularly if a tyrosine residue in the anti-
gen—combining site is iodinated [2, 33, 34]. Oxidation damage,
such as that caused by extended exposure to high concentra-
tions of chioramine T [3] is another potential cause of damage to
antibodies. Several methods of iodination are available, includ-
ing modifications of the chloramine T [2, 351, lactoperoxidase
[361 and iodine monochloride [371 techniques. A full description
of these is beyond the scope of this review and the reader is
referred elsewhere for an analysis of their advantages and
disadvantages [37, 38]. We have employed the chloramine T
method [41 more or less as modified by McConahey and Dixon
[3]. We generally iodinate 2 to 10 mg of IgG with ito 2 mCi of
125J or 131J as high—specific activity sodium iodide (New England
Nuclear, Boston, Massachusetts, USA) using 200 rg of
chloramine T (Eastman Kodak, Rochester, New York, USA) in
0.15 M sodium phosphate, pH 7.0. The reaction takes place on
ice in a volume of 1 to 3 ml for 10 mm and is quenched by
injecting 200 rg of sodium metabisuiphite. An excess of
unlabelled protein "carrier", such as IgG from the antibody
stock, nonspecific IgG or bovine serum albumin (BSA), is
added immediately after quenching, and free iodine is removed
by a combination of ion—exchange chromatography and either
extensive dialysis or gel—filtration chromatography. This
method allows us to achieve specific activities of 20 to 200
.tCi/mg of labelled lgG (approximately 0.001 to 0.01 iodine
atoms per IgG molecule) and 10 to 30% utilization of added
isotope. This degree of iodination is considerably less than that
found to produce protein denaturation (>1 iodine atom per
molecule) [2, 33, 371. By periodically screening labelled prepa-
rations as described above, we have also found no evidence of
oxidation injury using these conditions. Nevertheless, we rec-
ommend that individual investigators confirm this for them-
selves, particularly since different reagents, such as tissue
eluates and monoclonal antibodies, may be more susceptible to
injury.
In vivo binding of passively administered antibodies with
specificity for fixed or planted glomerular antigens
Methodology
Background. Radiolabelling techniques have been used to
detect the deposition of heterologous antibodies for almost four
decades. The earliest studies were by Pressman and colleagues
who examined the organ distribution of antibodies to crude
kidney fractions [39—41]. In a classic study of nephrotoxic
nephritis by Unanue and Dixon 142], the IgG fractions of rabbit
and duck antisera to a rat whole kidney preparation were
radiolabelled and injected into rats. Renal localization was
30 4 1
mm hrs days
Time after injection of 10 mg
anti-Fx1A-125l
Fig. 1. Kinetics of total kidney binding (TKAb) and glomerular binding
(GAb) of anti-FxJA IgG in passive Heymann nephritis TKAb and GAb
were determined in pairs of saline—perfused kidneys obtained from
individual rats injected intravenously with tO mg of anti-Fx IA lgG
trace—labelled with 123J Each point represents data from three or four
rats. GAb was measured on glomeruli isolated from each pair of kidneys
and calculated assuming 38,000 glomeruli/kidney. From [4].
calculated from the measured radioactivity in saline—perfused
whole rat kidneys, and the distribution was assumed to he
exclusively glomerular, based on IF microscopic findings that
showed linear staining of only the GBM. Based on these
observations, the kidney—fixing antibody (KFAh) content, ki-
netics of glomerular antibody binding and dissociation, and the
proteinuric threshold of various anti-kidney antibodies were
established [421. For several years this study, with certain
refinements such as the advent ofdouble—labelling techniques
[61, served as the prototype for subsequent studies that required
a quantitative analysis of glomerular antibody binding. Potential
pitfalls remained, however, and these are discussed below.
Distribution of kidney—fixing antibodies. As in the study by
Unanue and Dixon [421, it has often been assumed that the site
of renal localization of an heterologous antibody can be de-
duced from its location on IF microscopy. This assumption has
not been verified and, based on our own observations, is
probably incorrect. For example, Figure 1 shows the results of
total kidney binding (TKAb) and glomcrular binding (GAb) of
sheep IgG in pairs of saline—perfused kidneys at intervals tip to
five days from individual rats after intravenous injection with 10
TKAb
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mg of sheep anti-Fx1A. On IF, sheep IgG was seen exclusively
in glomeruli. Nevertheless, GAb (calculated on the assumption
that there are 38,000 glomeruli/rat kidney [40, 41]) accounted
for onty 20% (at 4 hours) to 40% (at 5 days) of TKAb. Atthough
recalculation of GAb based on a higher estimate of the number
of glomeruli per rat kidney than 38,000 [43, 441 slightly reduces
this discrepancy, there remains a substantial amount of anti-
body bound to cxtraglomerular renal tissues [4], which is not
readily appreciated by IF.
This discrepancy is true not only for anti-Fx1A that could,
conceivably, be invisibly bound to proximal tubular brush
border, hut also occurs with typical hetcrologous anti-GBM
antibody. In the following example, three rats were injected
with 2 mg of a pure IgG fraction of sheep anti-rat GBM that was
trace—labelled with 1251. After 24 hours, TKAb was 81.4 17.0
g/2 kidneys and GAb was 58.0 13.4 jsgI76,000 glomeruli,
giving a GAb:TKAb ratio of 71%. Similar observations have
been repeatedly made with various heterologous and eluted
autologous antibodies against a variety of fixed or planted
glomerular antigens, both in vivo and in the isolated perfused
rat kidney [7, 26, 45]. Thus, one cannot assume that TKAb truly
reflects GAb and, consequently, GAb must be determined by
additional techniques.
Methods for quantitating GAb. The amount of specifically
bound GAb is optimally determined in isolated glomeruli. At
nephrectomy, both the vascular and cxtravascular compart-
ments of the kidney are contaminated with exogenously admin-
istered IgG. To correct for plasma contamination, one may
either perfuse the kidneys with saline prior to ncphrcctomy, or
alternatively, employ the "double—isotope" technique [5, 61
described below.
Whereas whole kidneys removed 1 hour after an intravenous
injection of antibody have been shown to be contaminated with
the equivalent amount of IgG contained in 0.1 ml of blood [4,
42, 46], we found that residual IgG in isolated glomcruli from
kidneys perfused in vivo for 5 mm with 60 ml of heparinized
saline was equivalent to that in <0.003 ml of blood [4]. Because
this constitutes a trivial amount, we generally do not use the
double—isotope technique when immune reactants are to be
measured in glomeruli from saline perfused kidneys. Since the
yield of isolated glomeruli varies from one kidney to another
and rarely exceeds 50%, it is necessary to express GAb binding
as a function of some common denominator. We routinely
determine the yield of glomeruli after isotopic counting by
suspending them in 30% polyvinylpyrolidone and visually
counting five replicate aliquots in a Fuchs—Rosenthal hemocy-
tomctcr [4]. Although tedious, in our hands this method has the
least intra- and interassay variability. Other workers have
determined the protein content of alkali-hydrolyzed glomcruli
[47] or measured the weight of air—dried glomeruli [3, 13, 48].
The alternative approach to saline perfusion is the dou-
ble—isotope technique [5, 6]. Here, in addition to the iodinated
antibody, a radiolabelled plasma protein marker that does not
bind specifically to renal tissue (such as nonantihody IgG or
native BSA), is injected prior to removal of the kidneys. The
dose and time of injection of the marker should be selected to
ensure that there are adequate counts in the plasma at the time
of nephrcctomy. From the radioactive counts of the marker in
glomcruli (or whole kidneys) and of the marker and antibody in
an aliquot of plasma obtained at nephrcctomy, the proportion of
GAb that is nonspecifically trapped can he calculated and
specific binding determined [5, 6, 91. The disadvantage of this
technique is that it precludes the simultaneous comparison of
two isotopically labelled antibodies in the same kidney or
glomeruli thereof.
In contrast to glomeruli, the whole kidney is not adequately
freed of contaminating plasma proteins by saline perfusion [4].
Even after labelled nonspecific IgG has disappeared from the
blood, a small amount remains nonspecifically bound to renal
tissue or trapped in extravascular spaces from where it is not
removed by perfusion [4]. Thus when measuring specific bind-
ing of an immune reactant to whole kidney (TKAb), whether
perfused or not, it is necessary to apply either the dou-
ble—isotope technique (using a plasma marker similar to the
reagent of interest) or a correction factor for nonspecific binding
[4]. It must be pointed out, however, that even corrected TKAb
may not necessarily reflect GAb if substantial specific extraglo-
merular binding occurs, such as anti-FxIA binding to proximal
tubular brush border, or antibodies directed against GBM
components cross-reacting with tubular basement membrane.
Tracer studies. lsotopically—labelled antibodies or immuno-
gens are frequently used as tracers whose behavior is assumed
to reflect that of the much larger parent population of unlabelled
molecules. Small qualitative or quantitative differences in
glomerular binding characteristics between tracer and parent
antibody may not be critical when the effects of a given
manipulation are being compared in an experimental and con-
trol group injected with the same trace—labelled antibody prep-
aration. On the other hand, such differences are crucial when
absolute binding is to he measured. A slight reduction in affinity
of a labelled antibody, as compared to its parent population,
will lead to unequal competition for antigen, which will vary
according to the degree of antigen saturation. Furthermore,
complete destruction of the binding site of an unknown propor-
tion of labelled antibody molecules will result in an overestima-
tion of the number of labelled molecules in the final mixture that
arc capable of binding, and hence an underestimation of total
binding. As discussed earlier, these problems are generally
avoided by using radiolabelling conditions and a degree of
iodine substitution that are well within the safety range defined
for radioimmunoassay.
Application and interpretation at in vivo glotnerular
antibody binding
Interpretation of the results of therapeutic manipulations.
Quantitative techniques enable one to verify that manipulations
designed to modify the pathophysiological expression of depos-
ited antibody are not, instead, altering the amount of glomerular
binding. For example, rats injected with complement—fixing yl
antibodies to proximal tubular brush border (anti-FxIA) devel-
oped protcinuria while those given noneomplemcnt—fixing y2
anti-FxIA did not, despite similar amounts of GAb [24]. On the
other hand, rats given F(ab')2 anti-FxIA were also not protein-
uric, but we could not conclude that this was only due to the
absence of complement—fixation since, in itself, the amount of
GAb was probably insufficient to cause injury [24]. This appli-
cation of quantitative techniques is further demonstrated in
Table 2 which summarizes the results of GAb and proteinuria in
normal and C6-deficient rabbits injected wih labelled sheep
Quantitation of glo,nerular immune deposits 259
and recently with affinity—purified antibody to a planted glomer-
ular antigen [26].
It should be recognized that free antibody may not be a
constant fraction of the labelled lgCi in circulation over the
course of an experiment unless affinity—purified antibody is
used in a model that is frcc of circulating antigen. Theoretically,
immune complex formation, clearance by the mononu-
clear—phagocyte system and tissue deposition can all selectively
deplete the labelled, circulating probe of active antibody.
Therefore, one should actually measure the concentration of
•48h free antibody in circulation rather than the disappearance
kinetics of total IgG. This necessitates ultracentrifugation or
0 959 chromatography of each sample to determine the proportion of
counts that are associated with monomeric IgG, as well as an
assay for antigen—specific lgG. In practice we have most closely
approximately this ideal by using labelled, affinity—purified
antibody to a planted glomerular antigen in a transplant model
that has trivial or absent circulating antigen [261.
Ilemodynamic determinants of antibody deposition. Pro-
found effects on renal hemodynamics are observed with nephri-
togenic doses of various glomerular binding antibodies [54, 551.
These changes have been linked to complement fixation [541,
neurohumoral alterations [49], leukocyte infiltration [51], and
altered eicosanoid synthesis [561. Whether hemodynamic
changes are intrinsically induced by antibody or by extrinsic
mechanical or pharmacological maneuvers, they are likely to
affect antibody delivery and, theoretically, might alter IgG
permeation of the glomerular capillary wall [57] as well, thereby
influencing GAb. While the effects of hemodynamic alterations
on GAb binding have not been formally tested and need to be
defined, they have been shown to influence the deposition of
preformed immune complexes in dog kidney cortex [581 and of
macromolecules in the mesangiuni of rat glomeruli [591. Con-
sequently, when studying the effects on immunological glomer-
ular injury of conditions that may alter renal hemodynamics
(such as pharmacological blockade of putative inflammatory
mediators, complement depletion, unincphrectomy, age, sex,
dietary manipulation, renal artery or vein constriction, ureteral
obstruction, etc.) it is essential that GAb be measured to control
for their potential to alter antibody deposition [60],
Antibody content and affinity. When comparing GAb of
different antibody preparations, it is also important to deter-
mine their respective affinities for the relevant antigen and their
content of antigen—specific 1g. These are most effectively de-
fined when one uses affinity purified antibodies that have been
characterized according to affinity and antibody content as
described earlier.
Comparison cf glonierular binding of two antibodies. 'I'he
relative glomerular binding in vivo of two different antibody
preparations can be compared using dual—labelling techniques
in individual animals. The main advantage of this approach is
that each animal serves as its own control. Thus, potential
variables that could independently influence binding of each
antibody, if comparisons were made in separate animals, are
eliminated. In addition to the ones already mentioned, such
variables include the amount of glomerular antigen [46, 611 and
the recovery of glomeruli during isolation. When a study is
designed in this manner, renal plasma flow is a constant and
therefore one is required to correct glomerular binding of each
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Fig. 2. Relationship between glomeru/ar antibody binding (GAb) and
delivery of antibody to the kidneys of rats with passive Hevmann
nephritis. See the legend to Figure I for experimental details. GAb was
measured from one hour to five days after injection of anti-FxIA
[gG-'2I and antibody delivery was calculated as the product of the area
under the plasma concentration—time curve of IgG-'51 and estimated
renal blood flow. Each point is the average of values from three or four
rats. A direct linear relationship between the two measurements is
present.
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anti-GBM IgG [91. The results show that diminished proteinuria
in C6-deficicnt animals was clearly not due to reduced GAb.
Several other publications [4, 10, 49—52] contain examples of
this application of quantitative techniques, and the reader is
urged to examine them prior to designing experiments that
include immunological or pharmacological manipulations with
the potential to quantitatively alter the composition of glomer-
ular immune deposits.
iactors 1/mat may influence the in sit,! binding vtt antibodies to
fixed or planted glomerular antigens
Concentration and renal delivery of circulating antibody. A
major factor that determines the amount of antibody which
binds to glomerular antigens in vivo is the prevailing plasma
concentration of circulating IgG [25]. The latter, in turn, is
primarily dependent upon the injected dose [25. 461 as well as
catabolic rate [53]. When very small tracer doses of antibody
are injected, it is reasonable to assume that renal blood flow is
normal and constant. Antibody delivery to the glomerulus is
then directly proportional to plasma concentration, and is
calculated as the product of the area under the disappearance
curve of plasma antibody IgG and estimated renal blood flow
[25].
As shown in Figure 2, antibody binding in the glomerular
subepithelial space correlates linearly with the delivery of
antibody to the kidneys (r = 0.959). A similar relationship
between antibody binding and delivery has also been demon-
strated with heterologous anti-GBM and anti-Fx1A eluted from
rat kidneys [10, 25], eluted Heymann nephritis antibody [10]
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Table 3. Influence of antigen and antibody charge and the location of
antigen on glomerular antibody binding (GAb) [261.
Charge of Mean ratio of GAb
Site of antigen antigen cationic : anionic
Subepithelial cationic 1.19: 1
Subendothelial cationic 0.82: 1
Subendothelial anionic 1.13: 1
Cationic or anionic subclasses of sheep IgO were immunologically
planted on the subepithelial or subendothelial aspects of the GBM of rat
kidneys by injecting subnephritogenic doses of anti-FxlA or anti-GBM
respectively. These kidneys were transplanted into naive recipient rats
that were then passively immunized with dual—labelled, affinity—puri-
fied, catiooic and anionic fractions of rat anti-sheep IgG. GAb and
delivery of the two rat antibody fractions were measured in each
transplant recipient and the ratio of cationic : anionic GAb (corrected for
delivery) was calculated as described in the text. All values were
significantly different than 1:1 (P < 0.01, Student's paired t-test).
antibody for plasma concentration only. The results are then
expressed according to the following ratio [10, 261:
GAhI/area under plasma Abi concentration—time curve
GAb2/area under plasma Ab2 concentration—time curve
Charge interactions between antibody, antigen and the gb-
inerular capillary wall. The net anionic charge of the glomerular
barrier filter clearly influences the degree to which charged
macromolecules permeate the GBM and bind to fixed charge
residues [25, 62, 63]. This property has been used to great effect
in the study of in situ immune complex formation using a
variety of eationized proteins as planted glomerular antigens
[48, 641. In addition, several quantitative aspects of antibody
binding to a planted cationic antigen have been well defined.
Thus, Oite et at planted calionized human lgG in glomeruli of
rat kidneys by cx vivo perfusion and found that the amount of
intravenously injected labelled anti-IgG that bound was directly
related to the dose and concentration of circulating anti-IgG as
well as the amount of planted antigen [46]. Charge modification
has also been shown to influence the plasma clearance of
proteins [25, 27, 48, 65, 66] and immune complexes containing
such proteins [27]. Therefore, alterations in their delivery must
be considered in interpreting the effects of charge on the
glomerular localization of such proteins and complexes.
There is also evidence that glomerular charge—selective prop-
erties directly influence the binding of unmodified antibodies
with specificity for fixed glomerular antigens [25, 26]. However,
the charge relationships between antibody, antigen and glomer-
ular capillary wall are quite complex and their effect on GAb are
not readily predicted from antibody charge alone. Neverthe-
less, a small but definite influence of electrical charge on GAb
can be demonstrated when other variables (affinity, anti-
body—content, delivery, hemodynamics) are controlled [261.
These relationships are summarized in Table 3. In essence, the
negatively—charged glomerular filter favors the permeation of
positively charged antibodies directed at antigens located on the
epilhelial aspect of the GBM, whereas the charge of the antigen
appears to favor the binding of reciprocally—charged antibodies
when the antigen is located more proximal to the circulation
[261. Thus, when comparing the binding properties of different
antibodies, due consideration should be given to their respec-
tive charges as well as the location and charge of the relevant
antigen.
Quantitation of glomerular immune deposits in active
glomerulonephritis
A variety of approaches have been used in an attempt to
quantitate the immune response and glomerular immune depos-
its in actively immunized animals [6, 48, 66]. Serum immuno-
globulin concentrations provide no information on specific
antibody levels. Even if one has a soluble antigen to measure
the serum concentration of total [67] and/or precipitating [68]
antibody, such values do not necessarily indicate the potential
of circulating antibodies to form glomerular deposits [69].
Qaantitation of antigen. By immunizing rabbits with radio-
iodinated BSA, Wilson and Dixon were able to trace the
elimination of BSA from the circulation and its appearance in
glomeruli in acute serum sickness [6]. Considerable information
was obtained from this study including: the relationship be-
tween the rate of elimination of BSA from circulation and the
amount deposited in the kidney; the kinetics of BSA elimination
from kidney; the relationship between renal BSA and severity
of glomerulooephritis; and the masking of antigen by subse-
quently deposited antibody. Similarly, by substituting one daily
dose of BSA with radioiodinated BSA in rabbits developing
chronic serum sickness, the same authors obtained information
on the antigenic content of immune complexes being deposited
or forming in kidney at a moment in time before and after the
onset of overt glomerulooephritis [67]. They were also able to
simultaneously determine the size of BSA-containing immune
complexes in circulation, the half—life of kidney—bound BSA
and confirmed the accelerated clearance of BSA from kidney in
the presence of vast antigen excess [67]. Although the reoal—
bound fraction of injected BSA increased considerably during
the proteiouric phase of chronic serum sickness and suggested
a quantitative relationship between antigen deposition and
development of glomerular injury, this observation provided no
direct measurement of the total amount of glomerular—bound
antigen. Such information could only have been obtained by
trace labelling every dose of BSA, which would have been
impractical given the 4 to 10 week period of development of
glomerulonephritis, or alternatively, by the indirect method
described below for quantitation of endogenous antibody.
Qaantiiaiion of endogenous antibody. Experimental design
may require that a quantitative measurement be obtained of
endogenous antibody deposited in glomeruli. Indirect tech-
niques are generally required to achieve this end. In our
experience, acid—elution of antibodies from glomeruli, while
theoretically attractive, is not suitable for this purpose because
the IgG content and extent to which antibody is degraded vary
considerably from one batch of eluate to another, despite
apparently similar elution conditions. As discussed earlier,
immunofluorescent microscopy, at best, offers a semi-quanti-
tative assessment.
We recently developed a quantitative technique for establish-
ing the amount of host antibody deposited in the glomeruli of
animals that received a planted glomerular antigen [8]. This
assay was validated in the rat by demonstrating that binding of
anti-IgG to glomeruli in vitro is highly correlated with the
amount of antibody IgG deposited in vivo if incubation condi-
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intercept passing close to the origin), lends confidence to the
validity of the assay. Provided that conditions are standardized
as described [8] and incubations are done in parallel, this
technique is suitable in situations where there is need to
accurately quantitate, for comparative purposes, the amount of
host antibody deposited in tissue.
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